Next Article in Journal
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
Next Article in Special Issue
Advances in Thyroid Carcinoma
Previous Article in Journal
Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II Study
Previous Article in Special Issue
APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(8), 1951; https://doi.org/10.3390/cancers14081951
Action Date Notes Link
article xml file uploaded 13 April 2022 08:48 CEST Original file -
article xml uploaded. 13 April 2022 08:48 CEST Update -
article pdf uploaded. 13 April 2022 08:48 CEST Version of Record https://www.mdpi.com/2072-6694/14/8/1951/pdf-vor
article supplementary file uploaded. 13 April 2022 08:48 CEST - https://www.mdpi.com/2072-6694/14/8/1951#supplementary
article html file updated 13 April 2022 08:50 CEST Original file -
article xml file uploaded 15 April 2022 10:43 CEST Update -
article xml uploaded. 15 April 2022 10:43 CEST Update https://www.mdpi.com/2072-6694/14/8/1951/xml
article pdf uploaded. 15 April 2022 10:43 CEST Updated version of record https://www.mdpi.com/2072-6694/14/8/1951/pdf
article html file updated 15 April 2022 10:44 CEST Update -
article html file updated 2 August 2022 18:34 CEST Update https://www.mdpi.com/2072-6694/14/8/1951/html
Back to TopTop